Remove Las Vegas Remove Leadership Remove Retail Remove Technology
article thumbnail

Dunkin Earnings Go Light On Digital Acceleration

PYMNTS

Our marketing leadership team continues to create, assess and refine a phased approach for relaunching our brand responsibly at the right time. At Caesars, Auerbach oversaw marketing for the company’s Las Vegas portfolio and digital product development, third-party distribution and strategic partnerships.

Las Vegas 156
article thumbnail

Automakers Rev Up Venture Capital Engine With 38 Investments in 2017

PYMNTS

Automakers that want in on ridesharing, self-driving cars or innovative car financing options aren’t always developing their own technologies or starting their own ventures. But the company is licensed to test self-driving cars on the state’s roads in 2018, and it’s refining its technology and service with feedback from users.

Capital 109
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gonzo Notes from Money20/20

Gonzobanker

Recently, your intrepid Gonzo investigators found themselves (again) in Las Vegas to get a take on payments at Money20/20. (We We are rotating the team, as Misters Kilmer and Weikart reported that rehab from BAI Retail Delivery is taking a bit longer than estimated.) By Brandi Gregory, Nick Lane & Terence Roche.

article thumbnail

Amazon Walmart Whole Paycheck Tracker: Better Delivery By Any (And Every) Means

PYMNTS

This week was one of the latter, as Walmart hosted its investor meeting in Arkansas and Amazon decided this week’s menu of technological innovations in retail would be an all-you-can-eat buffet. The announcement was made by CEO of Worldwide Consumer Jeff Wilke on Wednesday (June 5) at the company’s “re:MARS” conference in Las Vegas.

Arkansas 109
article thumbnail

17 Of The Biggest Startup Frauds Of All Time

CB Insights

The problem was that Theranos’ proprietary blood-testing technology was completely fictitious. Holmes’ claims about Theranos’ blood-testing technology weren’t just exaggerations or selective interpretations of clinical research data; they were quite literally impossible. The Outcome. Total Funding: $263M.

Fraud 78